Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0M3AR
|
||||
Former ID |
DIB013801
|
||||
Drug Name |
L-168049
|
||||
Synonyms |
Glucagon antagonists (diabetes); L-168049; SCH-900822; Glucagon antagonists (diabetes), Merck & Co
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Diabetes [ICD9: 253.5, 588.1; ICD10:E23.2, N25.1] | Investigative | [540445] | ||
Company |
Merck Research Laboratories
|
||||
Structure |
Download2D MOL |
||||
Formula |
C24H20BrClN2O
|
||||
InChI |
InChI=1S/C24H20BrClN2O/c1-2-13-29-23-8-5-18(25)14-20(23)21-15-22(16-3-6-19(26)7-4-16)28-24(21)17-9-11-27-12-10-17/h3-12,14-15,28H,2,13H2,1H3
|
||||
InChIKey |
HHBOWXZOLYQFNY-UHFFFAOYSA-N
|
||||
CAS Number |
CAS 208188-17-4
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | Glucagon receptor | Target Info | Antagonist | [543641] | |
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.